03.20.2023
Quantabio Adds Powerful Bead Booster Chemistry to Ultra-Fast sparQ RNA-Seq HMR Kit
New optimizations increase yields up to 5x, accelerate workflows by more than 35% and reduce sample preparation costs by up to 30% BEVERLY,…
07.12.2022
Quantabio’s New qScript Ultra Product Family Builds on More Than 20 Years of RNA and DNA Enzyme Technology Innovation
Fast, flexible and easy-to-use qScript Ultra Flex Kit and qScript Ultra SuperMix enable scientists to reverse transcribe longer targets and maximize yields from challenging samples…
03.01.2022
Quantabio Launches Ultra-Fast RNA Library Prep Kit with Integrated Ribosomal RNA and Globin Depletion for Precision Oncology Applications
sparQ RNA-Seq HMR Kit generates high-quality Illumina® NGS sequencer-ready libraries from intact or degraded samples in a single day BEVERLY, Mass. – March 01…
07.12.2021
Quantabio’s UltraPlex 1-Step ToughMix Added to SalivaDirect – Emergency Use Authorization Protocol
Quantabio’s UltraPlex 1-Step ToughMix Added to SalivaDirect Emergency Use Authorization Protocol Ready-to-use, one-step master mix increases SARS-CoV-2 RT-PCR assay efficiency, sensitivity and specificity with minimal…
01.26.2021
Introducing sparQ UDI Adapters
Today we are launching our newest next generation sequencing product, sparQ UDI Adapters, to better enable you with a complete library prep solution for sequencing on…
11.03.2020
Introducing NEW sparQ Universal Library Quant Kit
sparQ Universal Library Quant Kit provides rapid and accurate quantification of libraries prepared for sequencing on Illumina® NGS platforms. Accurate quantification of the number of amplifiable…
09.09.2020
Launching NEW qScript 1-Step Virus ToughMix
qScript 1-Step Virus ToughMix is a 2x, ready-to-use, master mix for rapid detection of RNA viruses such as Flu-A, Flu-B, and SARS-CoV-2, using one-step, or…
07.16.2020
Quantabio’s UltraPlex 1-Step ToughMix Continues to Enhance CDC Protocols to Detect and Differentiate COVID-19 and Influenza Respiratory Diseases
CDC’s latest emergency use authorization for influenza SARS-CoV-2 assay validates Quantabio’s ability to multiplex up to five targets with high efficiency, sensitivity and specificity BEVERLY,…
07.01.2020
Quantabio RT-qPCR ToughMix Given Expanded Role in CDC COVID-19 Testing Protocol
Amended CDC emergency use authorization recognizes UltraPlex formulation in an effective heat treatment alternative for RNA extraction BEVERLY, Mass. – July 1, 2020 – Quantabio, a leading…
04.15.2020
CDC Adds Two Quantabio RT-qPCR ToughMix Kits to COVID-19 Diagnostic Testing Protocol
qScript XLT 1-Step RT-qPCR ToughMix and UltraPlex 1-Step ToughMix granted Emergency Use Authorization Quantabio’s qScript XLT 1-Step RT-qPCR ToughMix and UltraPlex 1-Step ToughMix have been…
02.25.2020
Quantabio Joins Forces with BioLegend to Improve Sample Processing for Single-Cell RNA Expression and Proteomic Studies
Highly efficient and reliable sparQ reagents enable TotalSeq™ customers to process up to 12 times more samples for the same cost as alternative products. Read…
10.15.2019
Quantabio to Showcase Industry’s Fastest qPCR-based NGS Library Quantification Kit and HiFi PCR Mix at American Society of Human Genetics Annual Meeting
Quantabio to Showcase Industry’s Fastest qPCR-based NGS Library Quantification Kit and HiFi PCR Mix at American Society of Human Genetics Annual Meeting Presentations to demonstrate…